Anna Franzén holds an MSc in Pharmaceutical Biosciences and a PhD in Toxicology from Uppsala University. With over 20 years’ experience in the pharmaceutical industry and regulatory environments, Anna has developed a deep expertise in safety assessment, clinical research and regulatory strategies.
